BNP Paribas Financial Markets
MIST icon

BNP Paribas Financial Markets’s Milestone Pharmaceuticals MIST Stock Holding History

BNP Paribas Financial Markets’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$210K Sell
176,504
-45,447
-20% -$79.6K ﹤0.01% 4030
2025
Q4 		$448K Buy
+221,951
New +$478K ﹤0.01% 3630
2025
Q2 		– Sell
-26,023
Closed -$20.8K – 5584
2025
Q1 		$20.8K Sell
26,023
-5,110
-16% -$10.2K ﹤0.01% 4529
2024
Q4 		$73.5K Buy
31,133
+1,924
+7% +$3.3K ﹤0.01% 4287
2024
Q3 		$44.4K Buy
29,209
+4,609
+19% +$6.71K ﹤0.01% 3634
2024
Q2 		$32.7K Buy
24,600
+7,700
+46% +$12.4K ﹤0.01% 3562
2024
Q1 		$30.3K Buy
16,900
+10,800
+177% +$17.5K ﹤0.01% 3618
2023
Q4 		$10.2K Buy
6,100
+4,000
+190% +$10.9K ﹤0.01% 3711
2023
Q3 		$6.51K Sell
2,100
-8,710
-81% -$27.1K ﹤0.01% 3655
2023
Q2 		$30.8K Buy
10,810
+8,659
+403% +$32.7K ﹤0.01% 3553
2023
Q1 		$8.47K Buy
2,151
+651
+43% +$2.38K ﹤0.01% 3559
2022
Q4 		$5.94K Buy
+1,500
New +$7.9K ﹤0.01% 3653
2022
Q2 		– Sell
-3,848
Closed -$24.7K – 4182
2022
Q1 		$24.7K Buy
+3,848
New +$24K ﹤0.01% 3697

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

BNP Paribas Financial Markets's MIST Position: Q1 2026 in Review

BNP Paribas Financial Markets reduced its Milestone Pharmaceuticals (MIST) stake by 20% in Q1 2026, selling an estimated $79.6K and leaving 176,504 shares worth $210K. The position accounts for ﹤0.01% of the portfolio, ranked #4030.

BNP Paribas Financial Markets first reported a position in MIST in Q1 2022 and has held it in 13 quarters since. The position peaked at $448K in Q4 2025. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • BNP Paribas Financial Markets held 176,504 shares of Milestone Pharmaceuticals worth $210K as of Q1 2026.
  • BNP Paribas Financial Markets sold 45,447 Milestone Pharmaceuticals shares in Q1 2026, an estimated $79.6K.
  • Milestone Pharmaceuticals made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #4030 holding.
  • BNP Paribas Financial Markets first reported a position in Milestone Pharmaceuticals in Q1 2022 and has held it in 13 quarters since.
  • BNP Paribas Financial Markets's Milestone Pharmaceuticals position peaked at $448K in Q4 2025.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.